Top 10 Warren Buffett Stocks To Buy For 2018


Why Trump Advisor Scaramucci Hates DOL Fiduciary Rule

Ron Rhoades: DOL Fiduciary Rule Is as Good as Dead (for Now)

FINRAs 5 Biggest Fine Categories in 2016

Warren Buffett’s track record at Berkshire Hathaway is stellar.

But the CEO of rising robo-advisor Betterment says Buffett’s advice to most investors — that they should buy S&P index funds and hold them — “doesn’t work anymore.”

The Oracle of Omaha spells out the secrets of his success in his yearly letter to Berkshire Hathaway shareholders.


You are signed up!

ThinkAdvisor’s TechCenter is an educational resource designed to give you a competitive edge by keeping you abreast of new tech innovations and need-to-know information that can be applied to your business. Resources STRAIGHT-THROUGH PROCESSING FOR THE FINANCIAL SERVICES INDUSTRY

STP can be described as electronically capturing and processing transactions in one pass, from the point of first ‘deal’ to final settlement.

Top 10 Warren Buffett Stocks To Buy For 2018: Maximus, Inc.(MMS)


Advisors’ Opinion:

  • [By Michael Flannelly]

    Analysts at Jefferies initiated coverage on business process services provider Maximus Inc. (MMS) late on Thursday, giving the stock a bullish rating because it has several competitive advantages and should benefit from the Affordable Care Act (Obamacare).

    The analysts rate MMS as “Buy” and see shares reaching $47. This price target suggests a 20% upside to the stock’s Thursday closing price of $39.14.

    “MMS is a leading government outsourced contractor that produces consistently strong results,” Jefferies analyst David Styblo commented. “The company has several competitive advantages and is highly focused on health and human service projects. This positions MMS to enjoy multi-year growth from the ACA and other opportunities with limited risk. The company’s predictable business model, solid balance sheet, and EPS visibility into FY2014 also support a Buy and $47 PT.”


    Maximus shares were inactive during pre-market trading on Friday. The stock is up 23.83% year-to-date.

  • [By ]

    Maximus Inc (NYSE: MMS) holds just $16 million in long-term debt against $886 million in shareholder equity. Shares trade for 1.7 times sales for a discount of 26% on the industry average of 2.3 times sales.

Top 10 Warren Buffett Stocks To Buy For 2018: Regeneron Pharmaceuticals, Inc.(REGN)

Advisors’ Opinion:

  • [By Todd Campbell, Demitrios Kalogeropoulos, and Reuben Gregg Brewer]

    In the case of these three stocks, however, it may be worth taking a gamble. Our contributors think catalysts at Regeneron Pharmaceuticals (NASDAQ:REGN), Royal Dutch Shell (NYSE:RDS-B), and United Parcel Service (NYSE:UPS) can get them back to their winning ways. Read on to find out if these down-and-out stocks are right for your portfolio.

  • [By Ben Levisohn]

    After years of rising and falling in tandem, the biotech sector is all about stock picking now. Credit Suisse analyst Alethia Young and team, for instance, upgraded Regeneron Pharmaceuticals (REGN), and added Celgene (CELG) to its Focus List today. But Amgen (AMGN) wasn’t so lucky as Young cut it to Neutral from Outperform. She explains why:

  • [By Chris Lange]

    Shares of Amgen Inc. (NASDAQ: AMGN) saw a handy gain to close out the week after the company won a Delaware court ruling that blocked Sanofi (NYSE: SNY) and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) from selling their cholesterol-lowering drug in the United States. Essentially the court found that the drug Praluent actually infringed upon Amgens patents for its rival treatment Repatha.

Top 10 Warren Buffett Stocks To Buy For 2018: Coherus BioSciences, Inc.(CHRS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Coherus Biosciences Inc (NASDAQ: CHRS) shares shot up 23 percent to $13.70 after the company announced plans to raise up to $150 million in a private placement.

  • [By Ben Levisohn]

    Today,Coherus BioSciences (CHRS) lost a patent case with AbbVie (ABBV) that would have allowed for a generic version of Humira. Citigroup’s Andrew Baum and Peter Verdult have the details:

    Agence France-Presse/Getty Images

    The Patent Trial and Appeal Boardjust announced that CHRSs IPR on the 166 Humira formulation patent was not instituted. We remind investors that Amgens IPR on the same 157 and 158 formulation patents were also not instituted. Any at risk launch on a formulation that potentially infringes 166, 157 or 158 would seem unlikely and carries a high risk thatAbbVie would attain a preliminary injunction. It is not clear whether either company could attempt launch with a formulation that does not infringe the patent estate. We note that Sandoz has uniquely not filed any IPR on any biosimilars. Sandoz has not announced the FDA has accepted their filing for their biosimilar adalimumab…We anticipate that the perceived historic relationship of the immunogenicity of Humira as it relates to dose stretching will form a key debate in the ongoing PTAB case…


    Following the decision of the PTAB not to institute CHRS IPR on the 166 Humira formulation patent, we continue to anticipate that first likely launch of biosimilar adalimumab (Humira) in the US will be delayed until 2020, in line with our published forecasts and biosimilar model. We anticipate the open IPR hearings for the 135 dosing patent on Humira (filed by Boehringer and Coherus) to begin in Feb 2017 with the ruling in May. We rateAbbVie a Buy. We continue to prefer BUY rated Bristol-Myers Squibb (BMY), Eli Lilly (LLY) among the US names.

    Shares of AbbVie have climbed 5.6% to $59.18 at 3:05 p.m. today, while Coherus BioSciences has tumbled 11% to $25.18,Bristol-Myers Squibb has gained 3% to $52.56, andEli Lilly has risen 1.7% to $73.70.

  • [By Lisa Levin] Gainers
    Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) shares rose 18.4 percent to $68.65 in pre-market trading as the company reported upbeat results for its first quarter.
    Jack in the Box Inc. (NASDAQ: JACK) shares rose 9.5 percent to $111.60 in the pre-market trading session after the company posted better-than-expected earnings for its second quarter. The company also disclosed that it has retained Morgan Stanley to evaluate potential alternatives for Qdoba.
    Coherus Biosciences Inc (NASDAQ: CHRS) rose 9.8 percent to $24.20 in pre-market trading. Coherus BioSciences disclosed that it prevailed in ‘135 IPR decision.
    Qiwi PLC (NASDAQ: QIWI) rose 8.1 percent to $21.49 in pre-market trading after reporting strong quarterly results.
    Korea Electric Power Corporation (ADR) (NYSE: KEP) shares rose 7.9 percent to $20.00 in pre-market trading after dropping 4.33 percent on Tuesday
    Target Corporation (NYSE: TGT) shares rose 7.5 percent to $58.60 in pre-market trading after the company reported stronger-than-expected results for its first quarter.
    AngloGold Ashanti Limited (ADR) (NYSE: AU) rose 4.3 percent to $11.71 in pre-market trading after falling 0.09 percent on Tuesday.
    Colgate-Palmolive Company (NYSE: CL) rose 4.1 percent to $74.53 in pre-market trading after the NY Post reported that the company might be up for sale for $100 per share.
    Harmony Gold Mining Co. (ADR) (NYSE: HMY) rose 4 percent to $2.35 in pre-market trading after declining 1.74 percent on Tuesday.
    Core Laboratories N.V. (NYSE: CLB) rose 3.6 percent to $109.00 in pre-market trading after gaining 0.39 percent on Tuesday.
    Clovis Oncology Inc (NASDAQ: CLVS) rose 3.2 percent to $51.15 in pre-market trading. JP Morgan upgraded Clovis Oncology from Neutral to Overweight.


    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top 10 Warren Buffett Stocks To Buy For 2018: First Capital Bancorp Inc.(VA)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows JetBlue Airways Corporation giving a good performance thats still not as good as that of large cap Southwest Airlines Co (NYSE: LUV) while the performance ofAlaska Air Group, Inc (NYSE: ALK), which has acquired Virgin America Inc (NASDAQ: VA), seems to have slipped recently:

Top 10 Warren Buffett Stocks To Buy For 2018: BioPharmX Corporation(BPMX)


Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of BioPharmX Corp (NYSE: BPMX) were down 31 percent to $1.02 after the company announced the pricing of 3.6 million share common stock.

    Puma Biotechnology Inc (NYSE: PBYI) was down, falling around 22 percent to $27.53 after the company issued an update to the timeline for the filing of a new drug application. Puma Biotechnology will submit the NDA for neratinib in mid-2016. According to a press release, the decision was based on the company’s recent meetings with the U.S. Food and Drug Administration.

Top 10 Warren Buffett Stocks To Buy For 2018: Daimler AG (DDAIF)


Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The recent news that Geely Automobile Holdings Ltd. (OTCPK:GELYF) has taken an approximate 10% share in Daimler AG (OTCPK:DDAIF) has shaken up the market. Geely already owns Volvo (OTCPK:VOLVY) cars and is a growing company investors might like to study carefully. Daimler already has a partnership with major auto manufacturer BAIC Motor Corp. (OTC:BCCMY) and with BYD. The joint venture with BYD has achieved little and this tie-up with Geely is seen as a source of some concern for BYD.

  • [By SEEKINGALPHA.COM]

    Other manufacturers are also planning to produce and sell all-electric trucks by the end of the current decade – Reuters reports that Navistar International Corp. (NYSE:NAV) and Volkswagen AG’s (OTCPK:VLKAF) Truck and Bus are working together to launch an electric medium duty truck by late 2019, while rival Daimler AG (OTCPK:DDAIF) has delivered the first of a smaller range of electric trucks to customers in New York. These are designed for shorter ranges than the Tesla semi but will likely see expanded ranges as battery technology advances.

  • [By SEEKINGALPHA.COM]

    Companies like Volvo (OTCPK:VOLVY), General Motors (NYSE:GM), Suzuki (OTCPK:SZKMF), Mercedes (OTCPK:DDAIF), and Ford (NYSE:F) are all using the small Swedish company’s tech. The most prominent use for zForce is in the dashboard infotainment center, but it’s also being used as gesture control for closing the tailgate or opening a door and even in using the steering wheel.

  • [By SEEKINGALPHA.COM]

    Apart from the locals, the global competitors have also made some quick moves to make their presence felt in China. According to Reuters, Volkswagen (OTCPK:VLKAY) has recently signed a preliminary deal to set up a joint venture with China-based Anhui Jianghuai Automobile (JAC) for making electric vehicles. However, the deal has enough hurdles in its path. Also, Daimler (OTCPK:DDAIY) (OTCPK:DDAIF) is also readying some electric cars for China under the Mercedes-Benz brand.

  • [By SEEKINGALPHA.COM]

    Through an alliance and investment in Nissan in 1999 Renault currently holds 43% of Japanese car manufacturer Nissan. Since 1999 Nissan has performed well and currently Nissan is worth $43B. Nissan is attractively valued with a P/E of 6.9 a P/B of 0.92 and P/S of 0.41 and a dividend yield of 4.2%. Renault’s stake of 43% in Nissan is worth ($43*0.43=) $18.5B. This means that the other operations of Renault including its 73.3% stake in leading Russian car manufacturer AutoVaz and 1.55% stake in Daimler are valued at only $8.5B. The market value of AutoVaz is $644M which means Renaults stake is worth approximately $472M. Daimler (OTCPK:DDAIF) is worth $77.4B which leads to a value of 1.2B for the 1.55% piece owned by Renault.

  • [By SEEKINGALPHA.COM]

    Last decennium, the popularity of both French Peugeot and Citro毛n has lost traction against that of German car manufacturers. PSA experienced declining sales, while German car manufacturers Volkswagen (OTCPK:VLKAY), BMW (OTCPK:BMWYY) and Daimler (OTCPK:DDAIF) have been stacking up sales records year after year over the last 6 years.

Top 10 Warren Buffett Stocks To Buy For 2018: Atwood Oceanics, Inc.(ATW)

Advisors’ Opinion:

  • [By Jason Hall]

    April was another bad month for offshore drilling stocks. Transocean Ltd. (NYSE:RIG), ENSCO Plc. (NYSE:ESV), Diamond Offshore Drilling Inc. (NYSE:DO), Atwood Oceanic Inc.(NYSE:ATW), and Noble Corporation (NYSE:NE) all held up relatively well through the first third of the month, but then start to fall around April 10.

  • [By Matthew DiLallo]

    Shares of Atwood Oceanics (NYSE:ATW) are bounding higher on Wednesday and were up more than 13% by 3:00 p.m. EDT. There wasn’t any news to drive the stock higher today. Instead, it appears that investors finally decided they like the company’s messy fiscal second-quarter report.

  • [By Lisa Levin]

    Energy sector was the top gainer in the US market on Wednesday. Top gainers in the sector included TETRA Technologies, Inc. (NYSE: TTI), CARBO Ceramics Inc. (NYSE: CRR), and Atwood Oceanics, Inc. (NYSE: ATW).

Top 10 Warren Buffett Stocks To Buy For 2018: Tiffany & Co.(TIF)

Advisors’ Opinion:

  • [By Peter Graham]

    Large cap luxury accessories stock Tiffany & Co (NYSE: TIF) reported Q3 earnings before the market openedWednesday morning with results helped by strong demand for its fashion jewelry along with higher sales in most regions includinga 15% sales increase in China. Worldwide net sales increased 3% to $976 million as comparable store sales declined 1%, reflecting sales growth in most regions, as well as increased sales in the Fashion Jewelry and the High, Fine & Solitaire Jewelry categories. On a constant-exchange-rate basis, worldwide net sales increased 3% and comparable store sales were equal to the prior year. Sales by region were as follows:

  • [By WWW.THESTREET.COM]

    Finally on Friday, Tiffany (TIF) reports, and Cramer is betting on positive news now that the company has an activist involved. He was also bullish on Amgen’s (AMGN) analyst meeting, saying investors should use any market weakness earlier in the week to buy.

  • [By Ben Levisohn]

    The SPDR S&P Retail ETF (XRT) is down again today, butinvestors continue to be attracted to Tiffany’s (TIF) shine.

    Tiffany has gained 1.2% to $95.06 at 3:27 p.m. today, what would be a new 52-week high if the stock closes there today. The SPDR S&P Retail ETF has fallen 0.2% to $40.87.

  • [By Paul Ausick]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Thursday was Tiffany & Co. (NYSE: TIF) which rose about 4.3% to $91.41. The stocks 52-week range is $66.35 to $97.29. Volume was 1.7 million compared to its average volume of 1.5 million.

  • [By Peter Graham]

    Large cap luxury accessories stock Tiffany & Co (NYSE: TIF) reported Q2 earnings before the market opened Thursday morning with a larger-than-expected quarterly profit and sales thanks in partto higher demand for its fashion and designer jewelry in Japan along with lower input costs. Worldwide net sales increased 3% to $960 million and comparable store sales declined 2% while on a constant-exchange-rate basis, worldwide net sales rose 4% and comparable store sales declined 1%.Management noted an increase in wholesale sales of diamonds, increased wholesale sales in the Asia-Pacific region and strong e-commerce sales growth. Overall, growth in fashion and designer jewelry sales contrasted with softness in other jewelry categories. Net sales by region were the following:

Top 10 Warren Buffett Stocks To Buy For 2018: Ligand Pharmaceuticals Incorporated(LGND)


Advisors’ Opinion:

  • [By Lisa Levin]

    Ligand Pharmaceuticals Inc. (NASDAQ: LGND) shares dropped 6 percent to $132.26. Deutsche Bank downgraded Ligand Pharmaceuticals from Hold to Sell.

  • [By Lisa Levin]

    In trading on Monday, healthcare shares were relative laggards, down on the day by about 0.51 percent. Meanwhile, top losers in the sector included Ligand Pharmaceuticals Inc. (NASDAQ: LGND), down 8 percent, and ImmunoGen, Inc. (NASDAQ: IMGN) down 7 percent.

  • [By Keith Speights]

    Research and development is the lifeblood of biotech companies. The potential for new drugs also serves as a primary factor driving biotech stocks higher and higher. That’s been the case for Celgene (NASDAQ:CELG), Ionis Pharmaceuticals (NASDAQ:IONS), and Ligand Pharmaceuticals (NASDAQ:LGND).

  • [By Keith Speights, Sean Williams, and Cory Renauer]

    So when we asked three of our top healthcare contributors to name three of the best stocks to invest in healthcare, it’s not surprising that their responses listed companies in three different industries: medical device makerMasimo (NASDAQ:MASI), pharmacy services giant CVS Health (NYSE:CVS) and biopharmaceutical company Ligand Pharmaceuticals (NASDAQ:LGND). Here’s why these three healthcare stocks stand out as smart picks.

Top 10 Warren Buffett Stocks To Buy For 2018: EXCO Resources NL(XCO)

Advisors’ Opinion:

  • [By Alex McGuire]

    These are the 10 best penny stocks that have seen the biggest returns over the last week (March 7 – March 14)…

    Penny StockCurrent PriceWeekly Gain (March 7 – March 14)Ocera Therapeutics Inc. (Nasdaq: OCRX)$1.47+147.1%Internap Corp. (Nasdaq: INAP)$3.28+41.4%Soligenix Inc. (Nasdaq: SNGX)$2.94+40%Navios Maritime Partners LP (NYSE: NMM)$2.63+37%QuickLogic Corp. (Nasdaq: QUIK)$2.14+30.5%Adamis Pharmaceuticals Corp. (Nasdaq: ADMP)$4.60+22.7EXCO Resources Inc. (NYSE: XCO)$0.65+20.5%Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC)$4.38+20.3%Hebron Technology Co. Ltd. (Nasdaq: HEBT)$3.99+19.1%Curis Inc. (Nasdaq: CRIS)$2.85+18.4%

    As a reminder, this is only a tracking metric of penny stocks trading on SEC-regulated exchanges like the Nasdaq and NYSE. Although these top penny stocks are safer than those trading on the pink sheets, we don’t recommend buying any of them without the proper amount of financial research.

Leave a Reply

Your email address will not be published. Required fields are marked *